151 related articles for article (PubMed ID: 21797811)
1. Bupropion-SR for smoking cessation in early recovery from alcohol dependence: a placebo-controlled, double-blind pilot study.
Karam-Hage M; Strobbe S; Robinson JD; Brower KJ
Am J Drug Alcohol Abuse; 2011 Nov; 37(6):487-90. PubMed ID: 21797811
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
[TBL] [Abstract][Full Text] [Related]
3. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
West R; Baker CL; Cappelleri JC; Bushmakin AG
Psychopharmacology (Berl); 2008 Apr; 197(3):371-7. PubMed ID: 18084743
[TBL] [Abstract][Full Text] [Related]
4. A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics.
Hays JT; Hurt RD; Decker PA; Croghan IT; Offord KP; Patten CA
Nicotine Tob Res; 2009 Jul; 11(7):859-67. PubMed ID: 19483180
[TBL] [Abstract][Full Text] [Related]
5. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia.
Evins AE; Mays VK; Rigotti NA; Tisdale T; Cather C; Goff DC
Nicotine Tob Res; 2001 Nov; 3(4):397-403. PubMed ID: 11694208
[TBL] [Abstract][Full Text] [Related]
6. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.
Tønnesen P; Tonstad S; Hjalmarson A; Lebargy F; Van Spiegel PI; Hider A; Sweet R; Townsend J
J Intern Med; 2003 Aug; 254(2):184-92. PubMed ID: 12859700
[TBL] [Abstract][Full Text] [Related]
7. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
Gonzales D; Rennard SI; Nides M; Oncken C; Azoulay S; Billing CB; Watsky EJ; Gong J; Williams KE; Reeves KR;
JAMA; 2006 Jul; 296(1):47-55. PubMed ID: 16820546
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
[TBL] [Abstract][Full Text] [Related]
9. Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.
Johnston JA; Fiedler-Kelly J; Glover ED; Sachs DP; Grasela TH; DeVeaugh-Geiss J
Nicotine Tob Res; 2001 May; 3(2):131-40. PubMed ID: 11403727
[TBL] [Abstract][Full Text] [Related]
10. Bupropion and nicotine patch as smoking cessation aids in alcoholics.
Grant KM; Kelley SS; Smith LM; Agrawal S; Meyer JR; Romberger DJ
Alcohol; 2007 Aug; 41(5):381-91. PubMed ID: 17889314
[TBL] [Abstract][Full Text] [Related]
11. Bupropion SR and contingency management for adolescent smoking cessation.
Gray KM; Carpenter MJ; Baker NL; Hartwell KJ; Lewis AL; Hiott DW; Deas D; Upadhyaya HP
J Subst Abuse Treat; 2011 Jan; 40(1):77-86. PubMed ID: 20934835
[TBL] [Abstract][Full Text] [Related]
12. Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction.
Evins AE; Cather C; Rigotti NA; Freudenreich O; Henderson DC; Olm-Shipman CM; Goff DC
J Clin Psychiatry; 2004 Mar; 65(3):307-11; quiz 452-3. PubMed ID: 15096068
[TBL] [Abstract][Full Text] [Related]
13. Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial.
Ahluwalia JS; Harris KJ; Catley D; Okuyemi KS; Mayo MS
JAMA; 2002 Jul 24-31; 288(4):468-74. PubMed ID: 12132977
[TBL] [Abstract][Full Text] [Related]
14. Bupropion SR vs placebo for smoking cessation in health care professionals.
Zellweger JP; Boelcskei PL; Carrozzi L; Sepper R; Sweet R; Hider AZ
Am J Health Behav; 2005; 29(3):240-9. PubMed ID: 15899687
[TBL] [Abstract][Full Text] [Related]
15. Use of sustained-release bupropion in specific patient populations for smoking cessation.
Tonstad S
Drugs; 2002; 62 Suppl 2():37-43. PubMed ID: 12109934
[TBL] [Abstract][Full Text] [Related]
16. Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
Hays JT; Ebbert JO
Drugs; 2010 Dec; 70(18):2357-72. PubMed ID: 21142259
[TBL] [Abstract][Full Text] [Related]
17. Bupropion-SR for smoking reduction and cessation in alcohol-dependent outpatients: a naturalistic, open-label study.
Karam-Hage M; Robinson JD; Lodhi A; Brower KJ
Curr Clin Pharmacol; 2014 May; 9(2):123-9. PubMed ID: 24218993
[TBL] [Abstract][Full Text] [Related]
18. Does bupropion have advantages over other medical therapies in the cessation of smoking?
Tonstad S; Johnston JA
Expert Opin Pharmacother; 2004 Apr; 5(4):727-34. PubMed ID: 15102559
[TBL] [Abstract][Full Text] [Related]
19. Tolerability and safety of sustained-release bupropion in the management of smoking cessation.
Aubin HJ
Drugs; 2002; 62 Suppl 2():45-52. PubMed ID: 12109935
[TBL] [Abstract][Full Text] [Related]
20. Late-term smoking cessation despite initial failure: an evaluation of bupropion sustained release, nicotine patch, combination therapy, and placebo.
Jamerson BD; Nides M; Jorenby DE; Donahue R; Garrett P; Johnston JA; Fiore MC; Rennard SI; Leischow SJ
Clin Ther; 2001 May; 23(5):744-52. PubMed ID: 11394732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
